Approach to the patient with an adrenal incidentaloma.
Unsuspected adrenal masses, or incidentalomas, are increasingly found with the widespread use of thoracic and abdominal imaging. These masses may be hormonally active or nonfunctional and malignant or benign. Clinicians must determine the nature of the mass to decide what treatment, if any, is needed. Measurement of precontrast Hounsfield units (HU) and contrast washout on computed tomography scan provide useful diagnostic information. All patients should undergo biochemical testing for pheochromocytoma, either with plasma or urinary catecholamine measurements. This is particularly important before surgical resection, which is routinely recommended for masses larger than 4 cm in diameter without a clear-cut diagnosis and for others with hormonal secretion or ominous imaging characteristics. Hypertensive patients should undergo biochemical testing for hyperaldosteronism. Patients with features consistent with Cushing's syndrome, such as glucose intolerance, weight gain, and unexplained osteopenia, should be evaluated for cortisol excess. Here, the dexamethasone suppression test and late-night salivary cortisol may be preferred over measurement of urine cortisol. The ability of surgical resection to reverse features of mild hypercortisolism is not well established. For masses that appear to be benign (<10 HU; washout, >50%), small (<3 cm), and completely nonfunctioning, imaging and biochemical reevaluation (pheochromocytoma and hypercortisolism only) at 1-2 yr (or more) is appropriate. For more indeterminate lesions, repeat evaluation for growth after 3-12 months is useful, with subsequent testing intervals based on the rate of growth.
Nieman
Lynnette K
LK
Program on Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-1109, USA. niemanl@nih.gov
D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D000465:Algorithms; D044963:Biopsy, Fine-Needle; D002277:Carcinoma / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D003480:Cushing Syndrome / Q000150:complications / Q000175:diagnosis; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D033162:Incidental Findings; D008875:Middle Aged; D017410:Practice Guidelines as Topic
J Endocrinol Invest. 2006 Apr;29(4):298-302
16699294
BJU Int. 2009 Sep;104(6):847-50
19389014
Ann Surg. 2009 Mar;249(3):388-91
19247023
J Clin Endocrinol Metab. 2001 Nov;86(11):5301-6
11701696
Best Pract Res Clin Endocrinol Metab. 2006 Sep;20(3):483-99
16980207
Eur J Endocrinol. 2009 Oct;161(4):513-27
19439510
J Clin Endocrinol Metab. 2000 Feb;85(2):637-44
10690869
Eur J Endocrinol. 2010 Jan;162(1):91-9
19797503
J Endocrinol Invest. 2010 Jan;33(1):32-6
19542759
Eur J Endocrinol. 2009 Jan;160(1):87-92
18835977
Surgery. 2007 Dec;142(6):900-5; discussion 905.e1
18063074
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):92-102
17237836
Arch Esp Urol. 2007 Mar;60(2):217-21
17484497
J Clin Endocrinol Metab. 2005 Feb;90(2):871-7
15572420
Radiology. 2008 Dec;249(3):756-75
19011181
Endocr Pract. 2010 Jul-Aug;16(4):577-87
20150023
Korean J Intern Med. 2005 Dec;20(4):303-9
16491828
Clin Endocrinol (Oxf). 2009 May;70(5):674-9
19067718
J Endocrinol Invest. 1997 Feb;20(2):65-71
9125485
Endocr J. 2005 Aug;52(4):463-9
16127216
Radiology. 2000 Dec;217(3):798-802
11110946
J Clin Endocrinol Metab. 2008 May;93(5):1526-40
18334580
Endocr J. 2008 Aug;55(4):737-45
18506093
Clin Endocrinol (Oxf). 2001 Jun;54(6):797-804
11422115
J Intern Med. 2002 Sep;252(3):239-46
12270004
World J Surg. 2006 Sep;30(9):1665-71
16927063
J Clin Endocrinol Metab. 2008 Sep;93(9):3266-81
18552288
Endocr J. 2003 Aug;50(4):399-408
14599113
Rev Endocr Metab Disord. 2007 Dec;8(4):309-20
17914676
J Clin Endocrinol Metab. 2009 Feb;94(2):456-62
19001518
N Engl J Med. 2007 Feb 8;356(6):601-10
17287480
J Clin Endocrinol Metab. 2006 Apr;91(4):1410-4
16403816
Endocr J. 2008 Mar;55(1):121-6
18202529
Eur J Endocrinol. 2009 Aug;161(2):355-61
19497985
Surgery. 2007 Oct;142(4):497-502; discussion 502-4
17950341
J Clin Endocrinol Metab. 1992 Mar;74(3):685-9
1311000
Endocrinol Metab Clin North Am. 2005 Jun;34(2):423-39, x
15850851
Endocr Relat Cancer. 2007 Sep;14(3):587-99
17914090
Endocrinol Metab Clin North Am. 2000 Mar;29(1):159-85, x
10732270
Surgery. 1991 Dec;110(6):1014-21
1745970
Ann Intern Med. 2003 Mar 4;138(5):424-9
12614096
Eur J Endocrinol. 2009 Apr;160(4):647-55
19174533
J Clin Endocrinol Metab. 2000 Apr;85(4):1440-8
10770179
Clin Endocrinol (Oxf). 1997 Jan;46(1):29-37
9059555
J Clin Endocrinol Metab. 1998 Jan;83(1):55-62
9435416
Eur J Endocrinol. 2006 Mar;154(3):419-23
16498055
Horm Res. 1997;47(4-6):284-9
9167966
AJR Am J Roentgenol. 1979 Feb;132(2):231-8
105590
Endocr Rev. 1995 Aug;16(4):460-84
8521790